120 related articles for article (PubMed ID: 3552083)
1. [Metastatic cancer of the breast. Study of intensive induction of remission chemotherapy. Controlled clinical trial].
Jouve M; Palangie T; Dorval T; Garcia-Giral E; Asselain B; Coutant M; Pouillart P
Bull Cancer; 1986; 73(6):683-4. PubMed ID: 3552083
[No Abstract] [Full Text] [Related]
2. Clinical trial of combined hormone therapy (MAP + TAM) for metastatic breast cancer.
Pannuti F; Martoni A; Piana E; Tomasi L; Grieco A; Farris A; Saccani F; Baroni M
Chemioterapia; 1984 Aug; 3(4):211-5. PubMed ID: 6241846
[TBL] [Abstract][Full Text] [Related]
3. Ixabepilone in metastatic breast cancer: complement or alternative to taxanes?
Tan AR; Toppmeyer DL
Clin Cancer Res; 2008 Nov; 14(21):6725-9. PubMed ID: 18980963
[No Abstract] [Full Text] [Related]
4. Management of recurrent breast cancer.
Robert NJ; Beveridge RA
Obstet Gynecol Clin North Am; 1994 Dec; 21(4):709-19. PubMed ID: 7731643
[TBL] [Abstract][Full Text] [Related]
5. [High-dose chemotherapy for metastatic breast cancer without certain advantages so far].
Kleeberg UR
Strahlenther Onkol; 2000 Jul; 176(7):334-5. PubMed ID: 10963001
[No Abstract] [Full Text] [Related]
6. [Metastatic breast cancer: controlled treatment trial of chemotherapy combined with hormone therapy using medroxyprogesterone alone or combined with tamoxifen].
Jouve M; Palangie T; Bretaudeau B; Garcia-Giralt E; Asselain B; Magdelenat H; Pouillart P
Bull Cancer; 1984; 71(2):148. PubMed ID: 6733294
[No Abstract] [Full Text] [Related]
7. Clinical trials referral resource. Metastatic breast cancer.
Cheson BD; Phillips PH; Abrams JS
Oncology (Williston Park); 1993 Dec; 7(12):43-4, 46. PubMed ID: 8292506
[No Abstract] [Full Text] [Related]
8. [Favorable remission rates of metastatic breast cancer with taxol therapy].
Med Klin Suppl; 1993 Nov; 2():10-3. PubMed ID: 7904714
[No Abstract] [Full Text] [Related]
9. Tamoxifen versus tamoxifen + mitoxantrone treatment in metastatic breast cancer.
Kars A; Baltali E; Tekuzman G; Firat D; Alakavuklar M
J Chemother; 1989 Jul; 1(4 Suppl):1196-7. PubMed ID: 16312831
[No Abstract] [Full Text] [Related]
10. [Combined chemotherapy of metastatic cancer of the breast].
Izmaĭlova GE; Letiagin VP; Starikova AB
Sov Med; 1988; (4):91-4. PubMed ID: 3406828
[No Abstract] [Full Text] [Related]
11. Chemotherapy for breast cancer. Part 2: Treatment of metastatic breast cancer.
Hill GJ
W V Med J; 1986 Aug; 82(8):267-9. PubMed ID: 3463009
[No Abstract] [Full Text] [Related]
12. Mitoxantrone and cyclophosphamide in advanced breast cancer: a pilot study.
McDonald DB; Abu-Zahra H; Yoshida S; Binder H
Semin Oncol; 1984 Sep; 11(3 Suppl 1):19-22. PubMed ID: 6385260
[TBL] [Abstract][Full Text] [Related]
13. Carboplatin in combination therapy for metastatic breast cancer.
Perez EA
Oncologist; 2004; 9(5):518-27. PubMed ID: 15477636
[TBL] [Abstract][Full Text] [Related]
14. On the relevance of "second-line" cytotoxic chemotherapy in patients with metastatic breast cancer resistant to standard combinations.
Petru E; Schmähl D
Wien Klin Wochenschr; 1986 Dec; 98(23):790-7. PubMed ID: 3811371
[TBL] [Abstract][Full Text] [Related]
15. Clinical trial design in metastatic breast cancer: a commentary.
Levine M
Can J Oncol; 1995 Dec; 5 Suppl 1():40-2. PubMed ID: 8853523
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy benefits nearly all early breast cancer patients.
McNeil C
J Natl Cancer Inst; 1997 Jun; 89(12):838-9. PubMed ID: 9196246
[No Abstract] [Full Text] [Related]
17. Combination chemotherapy with vinorelbine (Navelbine) and mitoxantrone for metastatic breast cancer: a review.
Vogel CL
Semin Oncol; 1995 Apr; 22(2 Suppl 5):61-5. PubMed ID: 7740335
[TBL] [Abstract][Full Text] [Related]
18. Multiple drug intensification after cyclophosphamide, doxorubicin, and 5-fluorouracil (CAF) induction in metastatic breast cancer: a Southeastern Cancer Study Group phase II trial.
Vogel CL; Raney M; Carpenter J
Cancer Treat Rep; 1987 Dec; 71(12):1271-3. PubMed ID: 3690536
[No Abstract] [Full Text] [Related]
19. [Chemotherapy of primary and metastasizing breast cancer].
Hofmann V; Martz G
Gynakol Rundsch; 1984; 24 Suppl 1():78-86. PubMed ID: 6394442
[No Abstract] [Full Text] [Related]
20. [Importance of the composition of various combination regimens in the chemotherapy of metastatic breast cancer].
Petru E; Schmähl D
Dtsch Med Wochenschr; 1987 Feb; 112(7):270-5. PubMed ID: 3545749
[No Abstract] [Full Text] [Related]
[Next] [New Search]
